CTS-Clinical and Translational Science

Papers
(The H4-Index of CTS-Clinical and Translational Science is 28. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)
ArticleCitations
Gene polymorphism and prediction of toxicity to platinum‐based chemotherapy in patients with gynecologic cancer262
Issue Information123
Intradermal substance P as a challenge agent in healthy individuals102
Issue Information99
79
Bridging Implementation Gaps in Digital Health: A Translational Research Imperative for Equitable Healthcare Innovation76
ST2 and CSF‐1 as potential druggable targets of inflammatory bowel diseases: Results from two‐sample Mendelian randomization study70
A Patient Centric Model for Vaso‐Occlusive Crises in Sickle Cell Disease—Outcomes of a Consensus Exercise Conducted Across Patients and Experts63
The impact of skin color and tone on histamine iontophoresis and Doppler flowmetry measurements as a pharmacodynamic biomarker58
CYP3A Genotype Is Associated With Variability in the Exposure and Clearance of the Novel Oncogenic Transcription Inhibitor Lurbinectedin53
Nontraditional Factors Influencing Cardiovascular Disease Risk: Correlation Among Framingham Risk Score, Body Composition Index, and Sleep‐Breathing Monitoring Index51
Japanese Phase 1 Study for Global Development of Anti‐TL1A Antibody PF‐06480605: A Randomized, Placebo‐Controlled, Single‐Ascending Dose Study49
A comprehensive Thai pharmacogenomics database (TPGxD‐1): Phenotype prediction and variants identification in 942 whole‐genome sequencing data48
Pharmacokinetics of Sofosbuvir/Velpatasvir and efficacy of an alternate‐day treatment in hemodialysis patients with chronic hepatitis C infection42
Perspectives on Using Pharmacogenomics to Guide Tobacco Cessation: Survey Results From an American Indian Community42
Patient, industry, and regulatory perspective on antibody‐drug conjugates dose optimization41
Developing a clinical research infrastructure embedded in an academic medicine center that equitably supports future clinician scientists39
Using partition analysis as a facile method to derive net clearances39
From Lab to Clinic: Effect of Academia–Industry Collaboration Characteristics on Oncology Phase 1 Trial Entry36
Generalizability in real‐world trials35
Mitigating ipatasertib‐induced glucose increase through dose and meal timing modifications35
The Effect of Diabetes Medication on the Scores of the GNRI and CONUT Nutritional Indices: Cross‐S34
Evidence of depot‐specific regulation of all‐trans‐retinoic acid biosynthesis in human adipose tissue33
First‐in‐human study of JNJ‐67571244, a CD33 × CD3 bispecific antibody, in relapsed/refractory acute myeloid leukemia and myelodysplastic syndrome30
Risk factors for the development of sepsis in patients with cirrhosis in intensive care units30
Pharmacogenomic landscape of Indian population using whole genomes29
First, Do No Harm: Addressing AI's Challenges With Out‐of‐Distribution Data in Medicine29
Expanding regulatory science: Regulatory complementarity and reliance29
0.19954895973206